Skip to content
Search

Latest Stories

Staffing crisis risks derailing attempts to solve hospital backlog, MPs warn

Attempts to deal with record waiting lists for hospital treatment caused by the Covid-19 pandemic are at risk of being derailed by a staffing crisis, which is being exacerbated by the Omicron wave, a cross-party lawmakers' report said on Thursday (January 6).

The report entitled ‘Clearing the backlog caused by the pandemic’ calls for a broader national health and care recovery plan -- one that would embrace A&E, mental health, GPs, community and social care.


Hospitals are facing extreme pressure as they try to catch up on months of operations that have been delayed and suspended during the pandemic, as Covid-19 hospitalizations rise once more and self-isolation hits staffing levels.

There is a record 5.8 million waiting list for elective care, the Health and Social Care Committee said, adding that a recent surge in the Omicron variant has pushed cases to record highs and intensified pre-existing issues.

"Our report finds that the government's recovery plans risk being thrown off course by an entirely predictable staffing crisis," committee chair Jeremy Hunt said, adding there was no clear plan to address a burnt-out workforce and 93,000 vacancies in the NHS.

"Far from tackling the backlog, the NHS will be able to deliver little more than day to day firefighting unless the government wakes up to the scale of the staffing crisis facing the NHS, and urgently develops a long-term plan to fix the issue."

The committee urged the health ministry to work with the state-run NHS to produce a recovery plan by April.

Prime minister Boris Johnson has warned that Omicron will make the next few weeks challenging, and that there will be staffing disruptions, as he aims to ride out the wave of infections without further restrictions in England.

With waiting times in October 2021 already the worst since records began, the committee said that there should be an independent assessment of the NHS workforce at least every 2 years to ensure enough doctors and nurses are being trained.

Report calls for robust workforce planning: RPS

Commenting on the report, chair of the Royal Pharmaceutical Society in England Thorrun Govind said: “Pharmacists and pharmacy teams across the health service have shown enormous dedication to patient care throughout the pandemic. This latest committee report highlights once again the urgent need for robust workforce planning and support.

“With winter pressures and a spike in Covid-related staff absences, this also means prioritising essential work, cutting unnecessary bureaucracy, and ensuring pharmacists can take adequate rest breaks. The pandemic has shown just how important it is that the Government and NHS support collaboration across health professions to maintain patient access to care.

"If we are to clear the immediate backlog of care from the pandemic and support the NHS recovery in the longer-term, then we must see investment in pharmacy as part of a comprehensive workforce strategy.”

More For You

Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
MHRA approves Pfizer Hympavzi (marstacimab) for haemophilia treatment

Marstacimab is currently being assessed by NICE and the Scottish Medicines Consortium for use on the NHS

gettyimages

Marstacimab approved for haemophilia treatment, Pfizer aims for NHS availability

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi(marstacimab) to prevent or reduce bleeding in patients aged 12 years and older, weighing at least 35kg, who have severe haemophilia A or B.

Developed by Pfizer scientists, this groundbreaking treatment is the first of its kind to target a protein involved in the blood clotting process.

Keep ReadingShow less
​Pope Francis

Pope Francis at the Vatican on December 4, 2024.

Photo by FILIPPO MONTEFORTE/AFP via Getty Images

His Holiness Mahant Swami Maharaj offers condolences to Catholic community following Pope Francis' passing

His Holiness Mahant Swami Maharaj, the spiritual leader and president of the Bochasanwasi Akshar Purushottam Swaminarayan Sanstha (BAPS), has expressed heartfelt condolences to the Catholic community worldwide following the passing of Pope Francis on Monday.

In a formal letter addressed to the members of the Roman Catholic Church, Mahant Swami Maharaj conveyed the deep sorrow of the BAPS Swaminarayan Hindu fellowship, acknowledging the Pope's passing as “a profound loss to the Catholic community and Christians around the world.”

Keep ReadingShow less
Pharmacies in Northern Ireland distribute free booklets to raise cancer awareness

Dr Anna Cullen, Public Health Registrar at the Public Health Agency and Clare Conroy, Community Pharmacist from Meigh Pharmacy in Co Down.

Photo credit: Community Pharmacy Northern Ireland

Pharmacies in Northern Ireland help raise cancer awareness

Community pharmacies across Northern Ireland are distributing a free information booklet to help raise public awareness of the signs and symptoms of cancer and promote early diagnosis.

The initiative is part of the ‘Be Cancer Aware’ campaign, which has been running in pharmacies since April and will continue through May as part of the Living Well service.

Keep ReadingShow less
CPE invites pharmacy owners to share their views on new CPCF funding settlement

What do you think should be the next priority for the Government?

gettyimages

Pharmacy owners asked to share their views on new CPCF arrangements

Community Pharmacy England (CPE) is urging pharmacy owners to share their views on the new Community Pharmacy Contractual Framework (CPCF) funding settlement ahead of its next full Committee meeting, scheduled for 30 April–1 May.

The Committee said it had agreed to the settlement "reluctantly," acknowledging that it represents a significant shift after years of real-terms funding cuts, while admitting that it’s “still not sufficient to match the continued scale of pressures facing pharmacy businesses.”

Keep ReadingShow less